Franklin FTSE Emerging Markets UCITS ETF IE0004I037N4Blend | Factsheet as of 31 January 2025 This is a marketing communication. Please refer to the prospectus of the UCITS and to the KIID before making any finalFund Overview investment decisions. Umbrella Franklin Templeton ICAV This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Fund Base Currency USD Fund Inception Date 22/10/2024 Investment Overview Valor Number 139358025 The Fund aims to provide exposure to large and mid-capitalisation stocks in emerging market countries globally. The Bloomberg - Fund seeks to track the performance of the FTSE Emerging Index NR (the "Index") as closely as possible, regardless ofISIN IE0004I037N4 whether the Index level rises or falls, while seeking to minimise as far as possible the tracking error between the Fund's Domicile Ireland performance and that of the Index. UCITS Yes Product StructurePhysical Performance Replication Methodology Full Replication Frequency of Index Under current legislation, we are not allowed to display performance data with less than a complete 12 month performance Reconstitution Quarterly record. Use of Income Accumulation Fiscal Year End 30 June Shares Outstanding 400,000 Benchmark(s) and Type FTSE Emerging Index-NR Comparator Charges Total Expense Ratio0.11%The charges are the fees the Fund charges to investors to cover the costs of running the Fund. Additional costs, including transaction fees, will also be incurred. These costs are paid out by the Fund, which will impact on the overall return of the Fund. Fund charges will be incurred in multiple currencies, meaning that payments may increase or decrease as a result of currency exchange fluctuations. The Total Expense Ratio for Franklin FTSE Emerging Markets UCITS ETF includes a fee waiver of 0.05% until 31 October 2026. The TER waiver will expire from 1 November 2026. Further information is set out in the “Fees and Expenses”section of the Prospectus.Fund Characteristics Fund Benchmark Total Net Assets $9.71 Million Number of Holdings1,428 Price to Book 1.87x1.91x Price to Earnings (12-Month Trailing) 14.79x 14.78x Franklin FTSE Emerging Markets UCITS ETFas of 31 January 2025 Top Equity Issuers (% of Total)Trading Information Fund ExchangeTickerCurrencyBloombergReutersSEDOL TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 10.81Borsa ItalianaEMERGEUR EMERG IM EMERG.MI BSGZ015 TENCENT HOLDINGS LTD 4.16Deutsche Börse Xetra EMGMEUR EMGM GR EMGM.DEBSGZ004 ALIBABA GROUP HOLDING LTD 2.49Euronext Paris Exchange EMERGEUR EMERG FP EMERG.PA BSLMXZ6 HDFC BANK LTD 1.43 London Stock Exchange EMER GBP EMER LN EMER.L BSJMF29 MEITUAN 1.37 London Stock Exchange EMGMUSD EMGM LN EMGM.LBSGYZZ1 RELIANCE INDUSTRIES LTD1.26SIX Swiss ExchangeEMERGUSDEMERG SWEMERG.SBSB7S01 PDD HOLDINGS INC 1.03 XIAOMI CORP 1.01 Portfolio Management CHINA CONSTRUCTION BANK CORP 1.00Years with FirmYears of Experience INFOSYS LTD 0.99 Dina Ting, CFA9 29Lorenzo Crosato, CFA 7 26 Geographic Allocation (% of Total)What are the Risks? Fund Benchmark China 30.51 30.72 The Fund does not offer any capital guarantee or protection and you may not get back the amount invested. The Fund is subject to the India 21.08 21.16 following risks which are materially relevant: Emerging markets risk: the risk related to investing in countries that have less developed Taiwan20.65 20.79 political, economic, legal and regulatory systems, and that may be impacted by political/economic instability, lack of liquidity ortransparency, or safekeeping issues. Index Tracking Risk: No financial instrument or set of investment techniques enables the returns of Saudi Arabia 4.66 4.68any Index to be reproduced or tracked exactly. Changes in the investments of any Sub-Fund and re-weightings of the relevant Index may Brazil 4.42 4.43 give rise to various transaction costs, operating expenses or inefficiencies which may adversely impact a Sub-Fund’s tracking of an Index. South Africa 2.99 3.28 Index License Risk: To utilise an Index, the Fund may need to have a licence agreement signed with the Index Provider. If, at any time in Mexico 2.07 2.09 respect of an Index, the licence granted terminates or disputed, impaired or ceases to exist ,the Directors may be forced to replace the United Arab Emirates 1.91 1.92 Index with another Index. Such a substitution or any delay in such a substitution may have an adverse impact on the Sub-Fund. Passive Others 11.4610.93 Investment Risk: An Index Tracking Sub-Fund will be negatively affected by general declines in the securities and asset classes Cash & Cash Equivalents0.25 0.00 represented in its Index. Because Index Tracking Sub-Funds are not “actively”managed, Market disruptions and regulatory restrictionscould have an adverse effect on an Index Tracking Sub-Fund's ability to adjust its exposure to the required levels.Complete information on the risks of investing in the Fund are set out in the Fund's prospectus. Sector Allocation (% of Total) Fund Benchmark Glossary Financials23.18 23.26 Total Expense Ratio: Total Expense Ratio (TER) includes the fees paid to the management company, the investment manager and the Information Technology21.83 21.90 depository, as well as certain other expenses. The TER is calculated by taking the relevant main material costs paid out over the 12-month Consumer Discretionary 13.4113.38 period indicated and dividing them by the average net assets over the same period. The TER does not include all expenses paid by thefund (for example, it does not include what the fund pays for buying and selling securities). For a comprehensive list of the types of costs Communication Services 8.86 8.96deducted from fund assets, see the prospectus. For recent all-in annual costs, as well as hypothetical performance scenarios that show Industrials7.08 6.99the effects that different levels of return could have on an investment in the fund, where applicable, see the KIID. For funds that lack 12 Materials 6.44 6.50 months of data, or for which TER is not likely to give a fair idea of likely future costs, the figure shown is an estimate. Product Structure: Consumer Staples5.15 5.19 The Product Structure indicates whether an ETF is holding physical securities (i.e. Physical) or whether it is tracking the index performance Energy 5.06 5.05 using derivatives (swaps, i.e. Synthetic). Methodology: The Methodology indicates whether an ETF is holding all index securities in the Others 8.75 8.77 same weight as the index (i.e. Physical Replication) or whether an optimised subset of index securities is used (i.e. Optimised) in order to Cash & Cash Equivalents0.25 0.00 efficiently track index performance. Comparator: Benchmark is used for comparing Fund performance, but is not a constraint to FundInvestment. Price to Book: The price per share of a stock divided by its book value (i.e., net worth) per share. For a portfolio, the valuerepresents a weighted average of the stocks it holds. Price to Earnings (12-Month Trailing) is the share price of a stock, divided by its Market Cap Breakdown (% of Equity) (USD) per-share earnings over the past year. For a portfolio, the value represents a weighted average of the stocks it holds. Fund <2.0 Billion 1.80Portfolio Data Information 2.0-5.0 Billion8.26Holdings are provided for information purposes only and should not be deemed a recommendation to buy or sell the securities 5.0-10.0 Billion 14.94mentioned. 10.0-25.0 Billion19.70 25.0-50.0 Billion14.39 >50.0 Billion40.92 Franklin FTSE Emerging Markets UCITS ETFas of 31 January 2025 Important Information This is a sub-fund ("Fund") of Franklin Templeton ICAV, an Irish collective asset-management vehicle. An investment in Franklin Templeton ICAV entails risks which are described in the latest prospectus or supplement and in the KIID. The Fund's documents are available in English, German and French from your local website or can be requested via FT's European Facilities Service available at www.eifs.lu/franklintempleton. In addition, a Summary of Investor Rights is available from www.franklintempleton.lu/summary-of-investor-rights. The summary is available in English. Franklin Templeton ICAV is notified for marketing in multiple EU Member States under the UCITS Directive. Franklin Templeton ICAV can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 93a of the UCITS Directive. For the avoidance of doubt, if you decide to invest, you will be buying units/shares in the Fund and will not be investing directly in the underlying assets of the Fund. Given the variety of investment options available today, we suggest investors seek guidance from a Financial Adviser. CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute. The Sub-Fund has been developed solely by Franklin Templeton. The Sub-Fund is not in any way connected to or sponsored, endorsed, sold or promoted by the London Stock Exchange Group plc and its group undertakings (collectively, the "LSE Group"). FTSE Russell is a trading name of certain of the LSE Group companies. All rights in the FTSE Russell Index (the "Index") vest in the relevant LSE Group company which owns the Index. "FTSE®" "Russell®", "FTSE Russell®", "MTS®", "FTSE4Good®", "ICB®" and "The Yield Book®," are trade mark(s) of the relevant LSE Group company and are used by any other LSE Group company under license. "TMX®" is a trade mark of TSX, Inc. and used by the LSE Group under license. The Index is calculated by or on behalf of FTSE International Limited or its affiliate, agent or partner. The LSE Group does not accept any liability whatsoever to any person arising out of (a) the use of, reliance on or any error in the Index or (b) investment in or operation of the Sub-Fund. The LSE Group makes no claim, prediction, warranty or representation either as to the results to be obtained from the Sub-Fund or the suitability of the Index for the purpose to which it is being put by Franklin Templeton. Indices are unmanaged, and one cannot invest directly in an index. They do not reflect any fees, expenses or sales charges. Important data provider notices and terms available at www.franklintempletondatasources.com. Issued by Franklin Templeton Investment Management Limited (FTIML) Registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL.ßTIML is authorised and regulated by the Financial Conduct Authority. UK Freephone: 0800 305 306 | email: enquiries@franklintempleton.co.uk | www.franklintempleton.co.uk